补充性和替代性药物和大麻使用在患有红色素质原形症的个体中
Emma Draisin1, Chloe Paige Rome1, Karli Hedstrom2
1Department of Genetics, Stanford University, Palo Alto, CA, United States of America.
Molecular genetics and metabolism
|December 16, 2025
概括
在Erythropoietic Protoporphyria (EPP) 中使用大麻可能有助于管理与症状相关的焦虑,但不是直接疼痛. 患有EPP的患者主要使用其他补充和替代药物 (CAM) 来改善整体健康,而不是缓解EPP症状.
科学领域:
- 遗传学和罕见疾病.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 染色体原 (EPP) 和X链接原 (XLP) 是罕见的遗传疾病,导致严重的皮肤对光的反应.
- 目前对EPP光毒反应的疼痛管理不足,需要新的治疗策略.
- 事证据表明,大麻可能会减轻EPP症状,这促使进一步调查.
研究的目的:
- 调查在被诊断患有EPP的人群中使用大麻和补充和替代药物 (CAM).
- 了解大麻使用的模式,包括使用原因和对EPP症状的感知影响.
主要方法:
- 对患有EPP和XLP的个体进行了横截面调查.
- 该调查评估了人口统计数据,EPP/XLP症状严重程度,CAM使用 (I-CAM-Q) 和大麻消费模式 (DFAQ-CU).
主要成果:
- 超过60%的参与者报告说他们过去或现在使用大麻,其中很大一部分是因为与欧洲人民党有关的原因而使用大麻.
- 据报道,大麻可以减轻围绕焦虑症状的焦虑,但不能直接减少EPP疼痛.
- 患有更严重EPP症状的个体报告大麻使用率更高.
- 大多数参与者使用其他CAM用于一般健康,而不是专门用于EPP症状.
结论:
- 大麻可能为EPB的次要影响提供好处,例如焦虑,而不是直接缓解疼痛.
- EPP患者主要使用CAM用于一般健康,而不是作为向的EPP治疗.
- 需要进一步的研究来探索大麻对EPP症状管理的治疗潜力,特别是EPP疼痛.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
651
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
651
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
436
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
436
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
236
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
236
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
424
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
424